Biosimilars Europe Congress 2017

The Biosimilars Europe Congress 2017 is dedicated to current vital issues, regulatory issues, market assessment and commercialization and globalization of Biosimilars.

Topics

• Monoclonal antibody Biosimilars.
• Current status of Biosimliars market.
• Opportunities in emerging markets.
• Challenges faced when moving towards globalization
• Partnership, new investment and business models.
• IP issues, naming and labeling issues related to biosimilars.
• Clinical trials strategies and new guidelines for biosimilar clinical trials.
• Challenges and opportunities for biobetters and monoclonal antibody biosimilars.
• Bringing biosimilars closer to patients and healthcare professionals.
• Benefits and concerns of interchangeable and biosubstitutes and post authorization monitoring.
• New solutions to demonstrate similarity and different characterization methods.